Beta Bionics, Inc.
BBNX· Nasdaq
BBNXBeta Bionics, Inc.
Filed Apr 21, 2026 · 10-Q · 21 days after period end · 0001193125-26-166843
| Metric | Q1 2026 | Q1 2025 | Q1 2024 |
|---|---|---|---|
| Revenue | $27.63M | $17.64M | $12.93M |
| Net Income | -$21.90M | -$28.66M | -$12.45M |
| EPS Diluted | -$0.49 | -$0.93 | -$2.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Beta Bionics, Inc. · CIK 1674632 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed Apr 21, 2026 · 21 d after period end
